Document is current
Any future updates will be listed below
-
Authors
Newsome, Scott D. https://orcid.org/0000-0002-5284-4681
Tian, Fan
Shoemaker, Thomas
Fitzgerald, Kathryn C.
Cassard, Sandra D.
Fiol, Julie
Snoops, Sarah
Cooper, David S.
Mammen, Jennifer S.R.
Bhargava, Pavan
Mowry, Ellen M.
Calabresi, Peter A.
-
Funding
Funding for this research was provided by:
National Multiple Sclerosis Society (RG 5184A2/1)
- License Information
-
More Information
This article is maintained by: Elsevier
Article Title: A Phase 1b, Open-Label Study to Evaluate the Safety and Tolerability of the Putative Remyelinating Agent, Liothyronine, in Individuals with MS
Journal Title: Neurotherapeutics
CrossRef DOI link to publisher maintained version: https://doi.org/10.1007/s13311-023-01402-3
Content Type: article
Copyright: Copyright © 2023 The American Society for Experimental NeuroTherapeutics, Inc. Published by Elsevier B.V. All rights reserved.
